What are the new prokinetic agents? Exploring innovative treatment options
•
5 min read
While older prokinetic agents like metoclopramide carry risks of severe neurological side effects, new prokinetic agents are emerging to address conditions like gastroparesis and functional dyspepsia with more targeted mechanisms and improved safety profiles. The therapeutic landscape for gastrointestinal motility disorders is evolving, offering new hope for millions affected by digestive issues.
